← Back to all trials
Active Not Recruiting
NCT05688098
Pharmacokinetics of Irbesartan/Amlodipine High FDC and Co-administration of Irbesartan and Amlodipine High in Healthy Volunteers
Conditions: Healthy Volunteers
Sex: All
Ages: 19 Years – N/A
Healthy volunteers: 1
Phase: PHASE1
Enrollment: 44
Sponsor: Handok Inc.
Location: Korea, Republic of
Summary
The purpose of this study is to compare pharmacokinetics and safety of Irbesartan and Amlodipine High Fixed Dose Combination and coadministration of mono compounds in healthy adult volunteers
Eligibility Criteria
Inclusion Criteria:Patients who are 19 years or older on screeningSigned informed consentHealthy VolunteerOther inclusion appliedExclusion Criteria:Clinically relevant/significant findings as evaluated by the investigatorOther exclusion applied
Source: ClinicalTrials.gov (NCT05688098). StuddyBuddy aggregates publicly available trial information.
